PharmaCyte Biotech, Inc. (PMCB) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 2.12M | 1.38M | 848.3K | 1.04M | 960.25K | 1.11M | 1.27M | 3.17M | 1.87M | 1.41M | 2.08M | 903.28K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 2.02M | 1.23M | 753.15K | 915.13K | 842.06K | 1.01M | 1.17M | 1.07M | 1.74M | 1.33M | 1.97M | 817.41K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 93.11K | 141.09K | 95.16K | 126.73K | 118.2K | 97.47K | 96.02K | 94.18K | 126.73K | 82.03K | 104.48K | 85.87K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -859 | 113 | 1000K | 54 | 480 | -1.85K | 0 |
| Operating Income | -2.12M | -1.38M | -848.3K | -1.04M | -960K | -1.11M | -1.27M | -3.17M | -1.87M | -1.41M | -2.08M | -903K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -120.64% | -24.42% | 33.15% | 67.09% | 48.64% | 21.56% | 38.84% | -250.61% | -20.35% | 39.2% | -23.44% | 40.12% |
| EBITDA | -2.12M | -1.38M | -8.36M | -1.04M | -960K | -1.11M | 0 | -132.86K | -1.87M | 0 | 0 | 283 |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -120.64% | -24.42% | - | -684.18% | 48.58% | - | - | -47047% | - | - | - | 100.02% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 1.27M | 3.03M | 1.87K | 1.41M | 2.08M | 903.28K |
| EBIT | -2.12M | -1.38M | -8.36M | -1.04M | -960K | -1.11M | -1.27M | -1.17M | -1.87M | -1.41M | -2.08M | -903K |
| Net Interest Income | 230.67K | 206.39K | 217.79K | 229.88K | 255.69K | 382.56K | 547.43K | 747.1K | 881.66K | 894.18K | 875.88K | 722.94K |
| Interest Income | 230.67K | 206.39K | 217.79K | 229.88K | 255.69K | 382.56K | 547.43K | 747.1K | 881.66K | 894.18K | 875.88K | 722.94K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.86M | -6.04M | -7.51M | 12.79M | -2.08M | -363K | 24.69M | 4.51M | 1.25M | 4.2M | -1.11M | 776.95K |
| Pretax Income | 746.86K | -7.42M | -8.36M | 11.75M | -3.04M | -1.47M | 23.42M | 1.35M | -620K | 2.79M | -3.18M | -126K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -1.56M | -7.42M | -8.36M | 11.75M | -3.04M | -1.47M | 23.42M | 1.35M | -620K | 2.79M | -3.18M | -126K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 48.89% | -404.62% | -135.69% | 772.28% | -391.13% | -152.69% | 835.82% | 1169.05% | -2609% | 293.48% | -106.02% | 91.15% |
| Net Income (Continuing) | 746.86K | -7.42M | -8.36M | 11.75M | -3.04M | -1.47M | 23.42M | 1.35M | -620K | 2.79M | -3.18M | -126K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.17 | -1.24 | -1.23 | 1.60 | -0.44 | -0.39 | 1.90 | -0.30 | -0.65 | -0.26 | -0.61 | -0.02 |
| EPS Growth % | 61.36% | -217.95% | -164.74% | 633.33% | 32.31% | -50% | 411.48% | -1134.57% | - | 7.14% | -103.33% | 91% |
| EPS (Basic) | -0.17 | -1.24 | -1.23 | 1.60 | -0.44 | -0.39 | 1.90 | -0.32 | -0.65 | -0.26 | -0.54 | -0.01 |
| Diluted Shares Outstanding | 9.26M | 6.8M | 6.8M | 6.8M | 6.96M | 7.64M | 7.87M | 8.35M | 8.61M | 8.77M | 5.18M | 5.18M |
| Basic Shares Outstanding | 9.26M | 6.8M | 6.8M | 6.8M | 6.96M | 7.64M | 7.87M | 8.04M | 8.61M | 10.83M | 12.6M | 16.79M |
| Dividend Payout Ratio | - | - | - | 137.79% | - | - | - | 99999900% | - | - | - | - |